Matrixyl 10% + HA is a separate peptide serum using Matrixyl technologies and hyaluronic-acid-related hydration. Its official product identity distinguishes it from both Argireline Solution and the Multi-Peptide + Copper Peptides serum. The product is classified here as a non-copper peptide alternative.
A percentage attached to a peptide blend is not a universal scale across peptide families. Matrixyl and GHK-Cu are different formulation stories, so ranking them by the largest printed number would be misleading. The useful tradeoff is a more focused peptide product versus a multi-ingredient serum or moisturizing cream, with attention to whether extra hydration is needed afterwards.
Read the actual formulation
Hyaluronic acid or sodium hyaluronate is discussed in the current ingredient information. The practical comparison is the non-copper peptide alternative ingredients and format, without treating the alternative as a GHK-Cu formula. The Ordinary Matrixyl 10% + HA is listed as non-copper peptide alternative, so its ingredient story should stay attached to that category. When the source does not establish a concentration or a complete base, we leave that detail open rather than fill it from another product.
A useful way to assess this option is to compare it with a product performing the same job. For The Ordinary Matrixyl 10% + HA, ask whether the attraction is the named active, the texture, the access route or a particular brand claim. Those reasons lead to different alternatives. A reader satisfied with an existing moisturizer may be choosing a treatment step; a reader mainly concerned about dryness may be deciding whether a separate serum adds anything useful.
Related reading: What copper peptides can—and cannot—tell you
The evidence question for this product
The Ordinary Matrixyl 10% + HA is identified here as non-copper peptide alternative. Copper-peptide research provides context for the broader directory, but it does not establish an effect for an alternative with a different formula. Assess the named ingredients and evidence on the actual finished product instead. The official source records the manufacturer’s product information; the formulation-specific details above support comparison without supplying an independent clinical outcome or a head-to-head superiority finding.
Routine fit and cautions
A copper-containing cosmetic can still sting or trigger a reaction to its base. Do not use a consumer serum to treat an open wound, recover from a procedure or replace clinician-directed care. With The Ordinary Matrixyl 10% + HA, the relevant discussion includes the non-copper peptide alternative ingredients and format, without treating the alternative as a GHK-Cu formula. Check the complete label and describe other leave-on products to a clinician if your skin is already irritated. A review cannot set a personal prescription schedule or identify the cause of a new skin change.
Compare the options in top 5 copper peptide creams & serums or read Bounce Back versus The Ordinary copper peptides.
Cost and the decision to buy
The source snapshot records $10.90 shown on the brand page. For The Ordinary Matrixyl 10% + HA, confirm the actual selected size, quantity and purchase terms on the official page. Compare a retail bottle, a prescription supply and a consultation over the same period; their headline figures are not interchangeable. Subscription or bundle pricing is a separate purchase option, not a reason to assume that more products are necessary.
Our decision point is the non-copper peptide alternative ingredients and format, without treating the alternative as a GHK-Cu formula. The information above helps decide what to read next and what needs clarification before purchasing The Ordinary Matrixyl 10% + HA. Use the related product review for a specific alternative and the category comparison to see the options together. If the ingredient identity, intended use or cost remains uncertain, the official manufacturer or treating clinician is the appropriate source for that missing detail.
Sources and verification
Official pages establish product facts and provider claims. Clinical and regulatory sources answer separate evidence questions. Checked October 1, 2026. No medical reviewer is credited for this article.